Fungal infections - An overview

Natalie Schellack*, Jade Du Toit, Tumelo Mokoena, Elmien Bronkhorst

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Fungi normally originate from the environment that surrounds us, and appear to be harmless until inhaled or ingestion of spores occurs. A pathogenic fungus may lead to infection. People who are at risk of acquiring fungal infection are those living with human immunodeficiency virus (HIV), cancer, receiving immunosuppressant therapy, neonates and those of advanced age. The management of superficial fungal infections is mainly topical, with agents including terbinafine, miconazole and ketoconazole. Oral treatment includes griseofulvin and fluconazole. Invasive fungal infections are difficult to treat, and are managed with agents including the azoles, echinocandins and amphotericin B. This paper provides a general overview of the management of fungus infections.

Original languageEnglish
Pages (from-to)33-40
Number of pages8
JournalSA Pharmaceutical Journal
Issue number1
Publication statusPublished - 2019


Dive into the research topics of 'Fungal infections - An overview'. Together they form a unique fingerprint.

Cite this